# A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

> **NCT04614467** · PHASE2 · TERMINATED · sponsor: **Lisata Therapeutics, Inc.** · enrollment: 34 (actual)

## Conditions studied

- Coronary Microvascular Dysfunction
- Coronary Microvascular Disease
- Microvascular Coronary Artery Disease

## Interventions

- **BIOLOGICAL:** CLBS16
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04614467
- **Lead sponsor:** Lisata Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-29
- **Primary completion:** 2022-09-28
- **Final completion:** 2022-09-28
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04614467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04614467, "A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04614467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*